Sinovac secured $15 million in funding to accelerate COVID-19 vaccine development
On May 22, 2020, Sinovac Biotech announced a transaction in which Advantech Capital and Vivo Capital have invested…
Analysis of COVID-19 genomes revealed large numbers of introductions to the UK in March, 2020
On May 22, 2020, data reports, published by the COVID-19 Genomics UK Consortium (COG-UK), showed the value in…
CIRM board expanded efforts of COVID-19 program
On May 22, 2020, the California Institute for Regenerative Medicine (CIRM) board expanded efforts related to the $5…
Biotechnology | COVID-19 | FDA
OraSures OMNIgene-ORAL kit included in EUA granted to P23 labs for at-home collection of saliva samples for SARS-CoV-2 test
On May 22, 2020, OraSure Technologies announced that its OMNIgene-ORAL saliva collection device (OM-505) was included in the…
Diversigen selected by Nom Nom as preferred provider for metagenomics and microbiome sequencing and analysis services
On May 22, 2020, Diversigen, an OraSure Technologies subsidiary, announced that Nom Nom had selected Diversigen as their…
The FDA posted list of antibody tests removed from the ‘notification list’ of tests being offered during the public health emergency
On May 21, 2020, the FDA posted list of antibody tests removed from the ‘notification list’ of tests…
Abbott announced contract to supply millions of IgG lab-based antibody tests to UK government
On May 21, 2020, Abbott announced a government contract to supply millions of its laboratory-based IgG antibody tests…
Abbott released interim clinical study data on ID NOW COVID-19 rapid test showing strong agreement to lab-based molecular PCR tests
On May 21, 2020, Abbott announced an interim analysis of an ongoing multi-site clinical study in urgent care…
AstraZeneca advanced response to global COVID-19 challenge as it receives first commitments for Oxford’s potential new vaccine
On May 21, 2020, AstraZeneca announced it was advancing its response to address the unprecedented challenges of COVID-19,…
bioMerieux serology tests for SARS-CoV-2 on VIDAS received CE marking
On May 21, 2020, bioMerieux announced the CE marking of VIDAS anti-SARS-CoV-2 serology tests to detect antibodies in…
University of British Columbia researchers developed biodegradable medical mask for COVID-19
On May 21, 2020, the BioProducts Institute at the University of British Columbia announced it had designed a…
University of British Columbia scientist identified a gene that controls thinness
On May 21, 2020, the BioProducts Institute at the University of British Columbia announced a study published in…
Innovation Pharma pursuing gold standard in battle gainst Covid-19
On May 21, 2020, Innovation Pharma announced that in vitro research independently conducted at a U.S. Regional Biocontainment…
ADMA Biologics commenced collection of COVID-19 plasma from recovered patients
On May 21, 2020, ADMA Biologics announced it had commenced the collection of convalescent plasma through its wholly-owned…
Amarin supported trial to investigate effects of VASCEPA (icosapent ethyl) in treatment of COVID-19
On May 21 2020, Amarin announced support for a clinical trial to investigate the effects of icosapent ethyl…
Study of BioAegis’ lead product, Gelsolin, key component of NIAID strategic plan for COVID-19 research
On May 21, 2020, BioAegis Therapeutics announced that the National Institute of Health Clinical Center began measuring patient…
Montefiore-Einstein Scientists lead two trials of leronlimab for treatment of severe lung inflammation in COVID-19 patients
On May 21, 2020, Montefiore Health System and Albert Einstein College of Medicine were the first sites in…
Roche acquired Stratos Genomics to further develop DNA based sequencing for diagnostic use
On May 21, 2020, Roche announced that it had acquired Seattle-based Stratos Genomics, an early-stage sequencing technology company…
Mammoth Biosciences collaborated with GSK to develop COVID-19 test using CRISPR-based platform
On May 20, 2020, Mammoth Biosciences announced a collaboration with GSK Consumer Healthcare to develop an accurate, easy-to-use,…
Kindred Biosciences announced COVID-19 vaccine manufacturing agreement with Vaxart
On May 20, 2020, Kindred Biosciences announced it had entered into an agreement with Vaxart for the manufacture…
Vaxart announced selection of its oral COVID-19 vaccine lead candidate
On May 20, 2020, Vaxart announced it had selected its lead COVID-19 vaccine candidate and had contracted with…
ViralClear closed $10.8 million equity financing for development of COVID-19 broad-spectrum oral anti-viral candidate merimepodib
On May 20, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the closing of a $10.8 million…
Rapid Micro Biosystems raised $120 million to accelerate global expansion of contaminant testing platform for pharmaceutical and vaccine manufacturing
On May 20, 2020, Rapid Micro Biosystems announced a $120 million financing round, led by equity investment from…
CHF Solutions publication highlighted use of ultrafiltration for fluid management in COVID-19 patients
On May 20, 2020, CHF Solutions announced a publication highlighting the use of ultrafiltration for fluid management of…
Airway Therapeutics and Celonic Group collaborated to produce AT-100 as promising new candidate for Coronavirus
On May 20, 2020, Airway Therapeutics and Celonic Group announced a collaboration to produce the novel human recombinant…
INOVIO COVID-19 DNA vaccine INO-4800 demonstrated robust neutralizing antibody and T cell immune responses in preclinical models
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
Bharat Biotech and Thomas Jefferson University announced a promising vaccine candidate against COVID-19
On May 20, 2020, Bharat Biotech and Thomas Jefferson University of Philadelphia announced an exclusive deal to develop…
Diffusion Pharma expanded clinical trial program of TSC for treatment of COVID-19 patients to include Romanian National Institute of Infectious Diseases
On May 20, 2020, Diffusion Pharmaceuticals announced it had entered into an agreement with the Romanian National Institute…
Atossa Therapeutics announced in vitro testing results of COVID-19 drug inhibits SARS-CoV-2 infectivity
On May 20, 2020, Atossa Therapeutics announced the successful results from in vitro testing of AT-H201, Atossaﾒs proprietary…
Phlow Corp was awarded $354 million BARDA contract to manufacture essential medicines in shortage
On May 19, 2020, Phlow, a U.S.-based, public benefit drug manufacturing corporation, received federal government funding of $354…